P-185 A prospective, randomized, controlled, multicenter phase III clinical trial of apatinib combined with neoadjuvant chemoradiotherapy for patients with locally advanced, HER2-negative, Siewert’s type II-III adenocarcinoma of esophagogastric junction

Phase Iii ◽

Type Ii ◽

Randomized Controlled ◽

Adenocarcinoma Of Esophagogastric Junction ◽

Multicenter Phase

CMISG1701: a multicenter prospective randomized phase III clinical trial comparing neoadjuvant chemoradiotherapy to neoadjuvant chemotherapy followed by minimally invasive esophagectomy in patients with locally advanced resectable esophageal squamous cell carcinoma (cT3-4aN0-1M0) (NCT03001596)

BMC Cancer ◽

10.1186/s12885-017-3446-7 ◽

2017 ◽

Vol 17 (1) ◽

Cited By ~ 10

Author(s):

Han Tang ◽

Lijie Tan ◽

Yaxing Shen ◽

Hao Wang ◽

Miao Lin ◽

...

Keyword(s):

Clinical Trial ◽

Squamous Cell Carcinoma ◽

Neoadjuvant Chemotherapy ◽

Minimally Invasive Esophagectomy ◽

Locally Advanced ◽

Phase Iii ◽

Invasive Esophagectomy ◽

Resectable Esophageal

A phase III clinical trial of neoadjuvant chemoradiotherapy followed by surgery versus surgery alone for locally advanced squamous cell carcinoma of the esophagus

Annals of Oncology ◽

10.1093/annonc/mdw371.03 ◽

2016 ◽

Vol 27 ◽

pp. vi207 ◽

Cited By ~ 1

Author(s):

H. Yang ◽

J. Fu ◽

M. Liu ◽

Y. Chen ◽

Z. Chen ◽

...

Keyword(s):

Clinical Trial ◽

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Squamous Cell ◽

Locally Advanced ◽

Phase Iii ◽

Advanced Squamous Cell Carcinoma ◽

Carcinoma Of The Esophagus ◽

F-048A PHASE III CLINICAL TRIAL OF NEOADJUVANT CHEMORADIOTHERAPY FOLLOWED BY SURGERY VERSUS SURGERY ALONE FOR LOCALLY ADVANCED SQUAMOUS CELL CARCINOMA OF THE OESOPHAGUS (NEOCRTEC5010)

Interactive Cardiovascular and Thoracic Surgery ◽

10.1093/icvts/ivx280.048 ◽

2017 ◽

Vol 25 (suppl_1) ◽

Author(s):

J Fu ◽

M Liu ◽

Y Chen ◽

Z Chen ◽

C Zhu ◽

...

Keyword(s):

Clinical Trial ◽

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Squamous Cell ◽

Locally Advanced ◽

Phase Iii ◽

Advanced Squamous Cell Carcinoma ◽

A phase III clinical trial of neoadjuvant chemoradiotherapy followed by surgery versus surgery alone for locally advanced squamous cell carcinoma of the esophagus.

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.tps4146 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. TPS4146-TPS4146

Author(s):

Hong Yang ◽

Jianhua Fu ◽

Mengzhong Liu ◽

Wentao Fang ◽

Jiaming Wang ◽

...

Keyword(s):

Clinical Trial ◽

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Squamous Cell ◽

Locally Advanced ◽

Phase Iii ◽

Advanced Squamous Cell Carcinoma ◽

Carcinoma Of The Esophagus ◽

Comparing Paclitaxel/5-Fluorouracil Versus Cisplatin/5-Fluorouracil in Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Cancer (ESO-Shanghai 1): A Randomized, Multicenter, Phase III Clinical Trial

SSRN Electronic Journal ◽

10.2139/ssrn.3269611 ◽

2018 ◽

Author(s):

Yun Chen ◽

Jinjun Ye ◽

Weixin Zhao ◽

Jialiang Zhou ◽

Chaoyang Wu ◽

...

Keyword(s):

Clinical Trial ◽

Squamous Cell ◽

Squamous Cell Cancer ◽

Cell Cancer ◽

Locally Advanced ◽

Esophageal Squamous Cell Cancer ◽

Phase Iii ◽

Multicenter Phase

A multicenter, double-blind, randomized, controlled phase III clinical trial of chicken type II collagen in rheumatoid arthritis

Arthritis Research & Therapy ◽

10.1186/ar2870 ◽

2009 ◽

Vol 11 (6) ◽

pp. R180 ◽

Cited By ~ 24

Author(s):

Wei Wei ◽

Ling-Ling Zhang ◽

Jian-Hua Xu ◽

Feng Xiao ◽

Chun-De Bao ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Clinical Trial ◽

Type Ii Collagen ◽

Phase Iii ◽

Type Ii ◽

Double Blind ◽

Randomized Controlled

Efficacy and Safety of 400 and 800 mg Etodolac vs. 1,000 mg Paracetamol in Acute Treatment of Migraine: A Randomized, Double-blind, Crossover, Multicenter, Phase III Clinical Trial

Pain Practice ◽

10.1111/j.1533-2500.2012.00572.x ◽

2012 ◽

Vol 13 (3) ◽

pp. 191-197 ◽

Cited By ~ 5

Author(s):

Vesile Öztürk ◽

Mustafa Ertaş ◽

Betül Baykan ◽

Hadiye Şirin ◽

Aynur Özge ◽

...

Keyword(s):

Clinical Trial ◽

Acute Treatment ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Multicenter Phase

166TiP Pembrolizumab combined with neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy followed surgery for locally advanced esophageal squamous cell carcinoma: Protocol for a multi-center, prospective, randomized-controlled, phase III clinical study (Keystone-002)

Annals of Oncology ◽

10.1016/j.annonc.2021.10.185 ◽

2021 ◽

Vol 32 ◽

pp. S1454-S1455

Author(s):

H. Jiang ◽

X. Shang ◽

C. Zhang ◽

J. Yue ◽

X. Duan ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Clinical Study ◽

Neoadjuvant Chemotherapy ◽

Esophageal Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Squamous Cell ◽

Locally Advanced ◽

Phase Iii ◽

Randomized Controlled

Monte Carlo simulation of a Markov Model for a phase III clinical trial evaluating the addition of total androgen suppression (TAS) to radiation versus radiation alone for locally advanced prostate cancer (RTOG 86–10)

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/s0360-3016(03)01028-9 ◽

2003 ◽

Vol 57 (2) ◽

pp. S215-S216 ◽

Cited By ~ 2

Author(s):

A.A Konski ◽

E Sherman ◽

M Krahn ◽

K Bremner ◽

J Beck ◽

...

Keyword(s):

Prostate Cancer ◽

Clinical Trial ◽

Monte Carlo Simulation ◽

Monte Carlo ◽

Advanced Prostate Cancer ◽

Locally Advanced ◽

Phase Iii ◽

Locally Advanced Prostate Cancer ◽

Androgen Suppression

Individualized Adaptive Radiotherapy versus Standard Radiotherapy with Chemotherapy for Patients with Locally Advanced Non-Small Cell Lung Cancer: A Multicenter Randomized Phase III Clinical Trial CRTOG1601

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2020.07.2286 ◽

2020 ◽

Vol 108 (3) ◽

pp. S105

Author(s):

S. Yuan ◽

Q. Yu ◽

S. Wang ◽

Y. Xu ◽

H. Ge ◽

...

Keyword(s):

Lung Cancer ◽

Clinical Trial ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Locally Advanced ◽

Small Cell ◽

Adaptive Radiotherapy ◽

Phase Iii ◽

Small Cell Lung ◽